This study is exploring a new way to see cancer using a special tool called a PET radiotracer. This tool is a kind of dye that lights up cancer cells in pictures taken inside the body. The study is using a new type of PET radiotracer called 68Ga-dPNE to target a protein called CD73, which is found in many cancers. The goal is to check how safe it is and how well it works compared to another tool called 18F-FDG.
The study is open to volunteers who are not pregnant and do not have serious liver or kidney problems. You will need to sign a consent form and be able to follow up with the researchers.
- This study involves a comparison of two imaging methods using PET scans.
- Participants should not be pregnant or have liver/kidney issues.
- Volunteers must sign a consent form and commit to follow-up visits.
How understandable was the trial content above?
Hard to understand
Easy to understand